Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
28
KPTI Quote, Financials, Valuation and Earnings
Last price:
$0.64
Seasonality move
:
14.23%
Day range:
$0.63 - $0.66
52-week range:
$0.63 - $1.95
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.55x
P/B ratio:
--
Volume:
1.3M
Avg. volume:
872.5K
1-year change:
-14.97%
Market cap:
$80.8M
Revenue:
$146M
EPS (TTM):
-$1.14
Karyopharm Therapeutics SEC Filings
| Company | Filed | Form Type | Description | |
|---|---|---|---|---|
|
KPTI
Karyopharm Therapeutics
|
05/08/2024 | 10-Q | 10-Q filing on 05/08/2024 | View Form |
|
KPTI
Karyopharm Therapeutics
|
11/02/2023 | 10-Q | 10-Q filing on 11/02/2023 | View Form |
|
KPTI
Karyopharm Therapeutics
|
08/02/2023 | 10-Q | 10-Q filing on 08/02/2023 | View Form |
|
KPTI
Karyopharm Therapeutics
|
05/04/2023 | 10-Q | 10-Q filing on 05/04/2023 | View Form |
|
KPTI
Karyopharm Therapeutics
|
11/03/2022 | 10-Q | 10-Q filing on 11/03/2022 | View Form |
|
KPTI
Karyopharm Therapeutics
|
08/04/2022 | 10-Q | 10-Q filing on 08/04/2022 | View Form |
|
KPTI
Karyopharm Therapeutics
|
05/05/2022 | 10-Q | 10-Q filing on 05/05/2022 | View Form |
|
KPTI
Karyopharm Therapeutics
|
11/03/2021 | 10-Q | 10-Q filing on 11/03/2021 | View Form |
|
KPTI
Karyopharm Therapeutics
|
08/05/2021 | 10-Q | 10-Q filing on 08/05/2021 | View Form |
|
KPTI
Karyopharm Therapeutics
|
05/04/2021 | 10-Q | 10-Q filing on 05/04/2021 | View Form |
|
KPTI
Karyopharm Therapeutics
|
11/02/2020 | 10-Q | 10-Q filing on 11/02/2020 | View Form |
|
KPTI
Karyopharm Therapeutics
|
08/04/2020 | 10-Q | 10-Q filing on 08/04/2020 | View Form |
|
KPTI
Karyopharm Therapeutics
|
05/05/2020 | 10-Q | 10-Q filing on 05/05/2020 | View Form |
|
KPTI
Karyopharm Therapeutics
|
02/26/2020 | 10-K | 10-K filing on 02/26/2020 | View Form |
|
KPTI
Karyopharm Therapeutics
|
11/04/2019 | 10-Q | 10-Q filing on 11/04/2019 | View Form |
|
KPTI
Karyopharm Therapeutics
|
08/07/2019 | 10-Q | 10-Q filing on 08/07/2019 | View Form |
|
KPTI
Karyopharm Therapeutics
|
05/09/2019 | 10-Q | 10-Q filing on 05/09/2019 | View Form |
|
KPTI
Karyopharm Therapeutics
|
02/28/2019 | 10-K | 10-K filing on 02/28/2019 | View Form |
|
KPTI
Karyopharm Therapeutics
|
11/08/2018 | 10-Q | 10-Q filing on 11/08/2018 | View Form |
|
KPTI
Karyopharm Therapeutics
|
08/07/2018 | 10-Q | 10-Q filing on 08/07/2018 | View Form |
|
KPTI
Karyopharm Therapeutics
|
05/10/2018 | 10-Q | 10-Q filing on 05/10/2018 | View Form |
|
KPTI
Karyopharm Therapeutics
|
03/15/2018 | 10-K | 10-K filing on 03/15/2018 | View Form |
|
KPTI
Karyopharm Therapeutics
|
11/02/2017 | 10-Q | 10-Q filing on 11/02/2017 | View Form |
|
KPTI
Karyopharm Therapeutics
|
08/08/2017 | 10-Q | 10-Q filing on 08/08/2017 | View Form |
|
KPTI
Karyopharm Therapeutics
|
05/04/2017 | 10-Q | 10-Q filing on 05/04/2017 | View Form |
|
KPTI
Karyopharm Therapeutics
|
03/16/2017 | 10-K | 10-K filing on 03/16/2017 | View Form |
|
KPTI
Karyopharm Therapeutics
|
11/07/2016 | 10-Q | 10-Q filing on 11/07/2016 | View Form |
|
KPTI
Karyopharm Therapeutics
|
08/04/2016 | 10-Q | 10-Q filing on 08/04/2016 | View Form |
|
KPTI
Karyopharm Therapeutics
|
05/09/2016 | 10-Q | 10-Q filing on 05/09/2016 | View Form |
|
KPTI
Karyopharm Therapeutics
|
03/15/2016 | 10-K | 10-K filing on 03/15/2016 | View Form |
|
KPTI
Karyopharm Therapeutics
|
11/09/2015 | 10-Q | 10-Q filing on 11/09/2015 | View Form |
|
KPTI
Karyopharm Therapeutics
|
08/10/2015 | 10-Q | 10-Q filing on 08/10/2015 | View Form |
|
KPTI
Karyopharm Therapeutics
|
05/11/2015 | 10-Q | 10-Q filing on 05/11/2015 | View Form |
|
KPTI
Karyopharm Therapeutics
|
03/13/2015 | 10-K | 10-K filing on 03/13/2015 | View Form |
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
